{"transactions":[{"id":747055,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-08T20:04:59.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":14492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14492},"source":{"system":"sec-edgar","filing":"0001193125-26-261691","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261691/ownership.xml","form_type":"4"}},{"id":747054,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-08T20:04:59.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":14492,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":130149,"source":{"system":"sec-edgar","filing":"0001193125-26-261691","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261691/ownership.xml","form_type":"4"}},{"id":757992,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-01T20:11:33.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":7242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":7242,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7242},"source":{"system":"sec-edgar","filing":"0001193125-26-251434","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526251434/ownership.xml","form_type":"4"}},{"id":955030,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-02T21:21:15.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":33505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options represent the Board's annual grant of options to directors of the Company. The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2026."}],"balance_after":33505,"derivative":{"exercise_price":1.94,"expiration_date":"2036-01-01","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":33505},"source":{"system":"sec-edgar","filing":"0001178913-26-000016","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891326000016/ownership.xml","form_type":"4"}},{"id":955029,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2026-01-02T21:21:15.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":38294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Board of Directors (\"Board\") of Entera Bio Ltd. (the \"Company\") awarded these shares to the Reporting Persons in lieu of the cash fees the Reported Person was entitled to for services rendered as a director of the Company for the 2025 fiscal year."}],"balance_after":338454,"source":{"system":"sec-edgar","filing":"0001178913-26-000016","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891326000016/ownership.xml","form_type":"4"}},{"id":1118889,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-09T20:13:42.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":14492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on June 5, 2025 and vest on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on June 5, 2025 and vest on June 5, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":14492,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14492},"source":{"system":"sec-edgar","filing":"0000950170-25-083736","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025083736/ownership.xml","form_type":"4"}},{"id":1118888,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-09T20:13:42.000Z","date":"2025-06-06","kind":"exercise","planned":false,"acquired":false,"shares":9632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 6, 2024 and vested on June 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 6, 2024 and vested on June 6, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9632},"source":{"system":"sec-edgar","filing":"0000950170-25-083736","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025083736/ownership.xml","form_type":"4"}},{"id":1118887,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-09T20:13:42.000Z","date":"2025-06-06","kind":"exercise","planned":false,"acquired":true,"shares":9632,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":115657,"source":{"system":"sec-edgar","filing":"0000950170-25-083736","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025083736/ownership.xml","form_type":"4"}},{"id":1179138,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-04-03T20:06:27.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":false,"shares":23952,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28509,"derivative":{"exercise_price":1,"exercise_date":"2023-12-22","expiration_date":"2028-12-22","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":23952},"source":{"system":"sec-edgar","filing":"0001178913-25-001192","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891325001192/ownership.xml","form_type":"4"}},{"id":1179137,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2025-04-03T20:06:27.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":true,"shares":23952,"price":1,"value":23952.0,"ownership":{"direct":true},"balance_after":300160,"source":{"system":"sec-edgar","filing":"0001178913-25-001192","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891325001192/ownership.xml","form_type":"4"}},{"id":1299876,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-17T21:30:58.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":28509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These options represent the Board's annual grant of options to directors of the Company. The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2025."}],"balance_after":28509,"derivative":{"exercise_price":2.28,"expiration_date":"2035-01-15","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":28509},"source":{"system":"sec-edgar","filing":"0001178913-25-000156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891325000156/ownership.xml","form_type":"4"}},{"id":1299875,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2025-01-17T21:30:58.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":10717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Board of Directors (\"Board\") of Entera Bio Ltd. (the \"Company\") awarded these shares to the Reporting Persons in lieu of the cash fees the Reported Person was entitled to for services rendered as a director of the Company for the fourth quarter of 2024."}],"balance_after":276208,"source":{"system":"sec-edgar","filing":"0001178913-25-000156","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891325000156/ownership.xml","form_type":"4"}},{"id":1390687,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2024-10-04T20:06:26.000Z","date":"2024-10-02","kind":"grant","planned":false,"acquired":true,"shares":11269,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":265491,"source":{"system":"sec-edgar","filing":"0001178913-24-003216","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891324003216/ownership.xml","form_type":"4"}},{"id":1419823,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2024-08-29T20:27:01.000Z","date":"2024-08-27","kind":"grant","planned":false,"acquired":true,"shares":27261,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":254222,"source":{"system":"sec-edgar","filing":"0001178913-24-002887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891324002887/ownership.xml","form_type":"4"}},{"id":1478055,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-06-17T11:20:44.000Z","date":"2024-06-15","kind":"exercise","planned":false,"acquired":false,"shares":21108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Share Units were granted on June 15, 2023 and vested on June 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Share Units were granted on June 15, 2023 and vested on June 15, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":21108},"source":{"system":"sec-edgar","filing":"0000950170-24-074009","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024074009/ownership.xml","form_type":"4"}},{"id":1478054,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-06-17T11:20:44.000Z","date":"2024-06-15","kind":"exercise","planned":false,"acquired":true,"shares":21108,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":106025,"source":{"system":"sec-edgar","filing":"0000950170-24-074009","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024074009/ownership.xml","form_type":"4"}},{"id":1485679,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-06-10T11:38:28.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":9632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 6, 2024 and vest on June 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 6, 2024 and vest on June 6, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":9632,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9632},"source":{"system":"sec-edgar","filing":"0000950170-24-071068","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024071068/ownership.xml","form_type":"4"}},{"id":1691515,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T21:12:55.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":108333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2024."}],"balance_after":108333,"derivative":{"exercise_price":0.6,"expiration_date":"2034-01-01","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":108333},"source":{"system":"sec-edgar","filing":"0001178913-24-000047","document":"zk2430732.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891324000047/zk2430732.xml","form_type":"4"}},{"id":1699398,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to buy)","published_at":"2023-12-27T22:00:37.000Z","date":"2023-12-22","kind":"purchase","planned":false,"acquired":true,"shares":23952,"price":0.125,"value":2994.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person entered into a Securities Purchase Agreement with the Issuer on December 20, 2023, pursuant to which, on December 22, 2023, the Reporting Person acquired an aggregate of 23,952 units for a purchase price of $0.835 per unit, each unit consisting of one share of the Issuer's ordinary shares, par value NIS 0.0000769 per share (\"Ordinary Shares\"), and one warrant, exercisable to purchase an Ordinary Share at an exercise price of $1.00 per share. The purchase price for each unit included $0.125 for the warrant in accordance with Nasdaq rules."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person entered into a Securities Purchase Agreement with the Issuer on December 20, 2023, pursuant to which, on December 22, 2023, the Reporting Person acquired an aggregate of 23,952 units for a purchase price of $0.835 per unit, each unit consisting of one share of the Issuer's ordinary shares, par value NIS 0.0000769 per share (\"Ordinary Shares\"), and one warrant, exercisable to purchase an Ordinary Share at an exercise price of $1.00 per share. The purchase price for each unit included $0.125 for the warrant in accordance with Nasdaq rules."}],"balance_after":23952,"derivative":{"exercise_price":1,"exercise_date":"2023-12-22","expiration_date":"2028-12-22","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":23952},"source":{"system":"sec-edgar","filing":"0001178913-23-003988","document":"zk2330700.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891323003988/zk2330700.xml","form_type":"4"}},{"id":1699397,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2023-12-27T22:00:37.000Z","date":"2023-12-22","kind":"purchase","planned":false,"acquired":true,"shares":23952,"price":0.71,"value":17005.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person entered into a Securities Purchase Agreement with the Issuer on December 20, 2023, pursuant to which, on December 22, 2023, the Reporting Person acquired an aggregate of 23,952 units for a purchase price of $0.835 per unit, each unit consisting of one share of the Issuer's ordinary shares, par value NIS 0.0000769 per share (\"Ordinary Shares\"), and one warrant, exercisable to purchase an Ordinary Share at an exercise price of $1.00 per share. The purchase price for each unit included $0.125 for the warrant in accordance with Nasdaq rules."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person's aggregate amount of Ordinary Shares in the Reporting Person's previous filings was inadvertently overstated by 11,200 shares. The aggregate amount has been properly adjusted in this Form 4."}],"balance_after":226961,"source":{"system":"sec-edgar","filing":"0001178913-23-003988","document":"zk2330700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891323003988/zk2330700.xml","form_type":"4"}},{"id":1798518,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2023-08-23T13:28:13.000Z","date":"2023-08-21","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.5892,"value":11784.0,"ownership":{"direct":true},"balance_after":214209,"source":{"system":"sec-edgar","filing":"0001178913-23-002974","document":"zk2330218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891323002974/zk2330218.xml","form_type":"4"}},{"id":1814238,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-08-07T20:05:41.000Z","date":"2023-08-04","kind":"exercise","planned":false,"acquired":false,"shares":15810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on August 4, 2022 and vested on August 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on August 4, 2022 and vested on August 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":15810},"source":{"system":"sec-edgar","filing":"0001209191-23-044783","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123044783/doc4.xml","form_type":"4"}},{"id":1814237,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-08-07T20:05:41.000Z","date":"2023-08-04","kind":"exercise","planned":false,"acquired":true,"shares":15810,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":84917,"source":{"system":"sec-edgar","filing":"0001209191-23-044783","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123044783/doc4.xml","form_type":"4"}},{"id":1850667,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-06-20T11:34:41.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":21108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 15, 2023 and vest on June 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 15, 2023 and vest on June 15, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":21108,"derivative":{"underlying":"Ordinary Shares","underlying_shares":21108},"source":{"system":"sec-edgar","filing":"0001209191-23-038220","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123038220/doc4.xml","form_type":"4"}},{"id":2066438,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-04T21:20:32.000Z","date":"2023-01-02","kind":"grant","acquired":true,"shares":89041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest ratably on a quarterly basis over a one-year period that commenced on January 2, 2023."}],"balance_after":89041,"derivative":{"exercise_price":0.73,"expiration_date":"2033-01-02","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":89041},"source":{"system":"sec-edgar","filing":"0001178913-23-000053","document":"zk2328963.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891323000053/zk2328963.xml","form_type":"4"}},{"id":2115954,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2022-11-15T21:07:50.000Z","date":"2022-11-14","kind":"purchase","acquired":true,"shares":4000,"price":0.59,"value":2360.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":6200,"source":{"system":"sec-edgar","filing":"0001178913-22-004052","document":"zk2228762.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891322004052/zk2228762.xml","form_type":"4"}},{"id":2115953,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2022-11-15T21:07:50.000Z","date":"2022-11-14","kind":"purchase","acquired":true,"shares":4000,"price":0.56,"value":2240.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":6200,"source":{"system":"sec-edgar","filing":"0001178913-22-004052","document":"zk2228762.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891322004052/zk2228762.xml","form_type":"4"}},{"id":2115952,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2022-11-15T21:07:50.000Z","date":"2022-11-14","kind":"purchase","acquired":true,"shares":4000,"price":0.56,"value":2240.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":6200,"source":{"system":"sec-edgar","filing":"0001178913-22-004052","document":"zk2228762.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891322004052/zk2228762.xml","form_type":"4"}},{"id":2115951,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2022-11-15T21:07:50.000Z","date":"2022-11-14","kind":"purchase","acquired":true,"shares":4000,"price":0.56,"value":2240.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":6200,"source":{"system":"sec-edgar","filing":"0001178913-22-004052","document":"zk2228762.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891322004052/zk2228762.xml","form_type":"4"}},{"id":2115950,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2022-11-15T21:07:50.000Z","date":"2022-11-14","kind":"purchase","acquired":true,"shares":34000,"price":0.57,"value":19380.0,"ownership":{"direct":true},"balance_after":194209,"source":{"system":"sec-edgar","filing":"0001178913-22-004052","document":"zk2228762.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891322004052/zk2228762.xml","form_type":"4"}},{"id":2192411,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-08-08T11:19:15.000Z","date":"2022-08-04","kind":"grant","acquired":true,"shares":15810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on August 4, 2022 and vest on August 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on August 4, 2022 and vest on August 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":15810,"derivative":{"underlying":"Ordinary Shares","underlying_shares":15810},"source":{"system":"sec-edgar","filing":"0001209191-22-044693","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122044693/doc4.xml","form_type":"4"}},{"id":2202643,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2022-07-25T21:16:27.000Z","date":"2022-07-21","kind":"purchase","acquired":true,"shares":19491,"price":1.683,"value":32803.353,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.664 to $1.702, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company (\"Entera Bio\"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":160209,"source":{"system":"sec-edgar","filing":"0001178913-22-002762","document":"zk2228172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891322002762/zk2228172.xml","form_type":"4"}},{"id":2230753,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-06-16T11:36:52.000Z","date":"2022-06-14","kind":"exercise","acquired":false,"shares":14479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 14, 2021 and vested on June 14, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 14, 2021 and vested on June 14, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14479},"source":{"system":"sec-edgar","filing":"0001209191-22-037248","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122037248/doc4.xml","form_type":"4"}},{"id":2230752,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-06-16T11:36:52.000Z","date":"2022-06-14","kind":"exercise","acquired":true,"shares":14479,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":69107,"source":{"system":"sec-edgar","filing":"0001209191-22-037248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122037248/doc4.xml","form_type":"4"}},{"id":2427593,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2022-01-24T21:15:59.000Z","date":"2022-01-18","kind":"purchase","acquired":true,"shares":700,"price":2.8083,"value":1965.81,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2200,"source":{"system":"sec-edgar","filing":"0001178913-22-000217","document":"zk2227103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891322000217/zk2227103.xml","form_type":"4"}},{"id":2427592,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2022-01-24T21:15:59.000Z","date":"2022-01-18","kind":"purchase","acquired":true,"shares":700,"price":2.7848,"value":1949.36,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2200,"source":{"system":"sec-edgar","filing":"0001178913-22-000217","document":"zk2227103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891322000217/zk2227103.xml","form_type":"4"}},{"id":2427591,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2022-01-24T21:15:59.000Z","date":"2022-01-18","kind":"purchase","acquired":true,"shares":700,"price":2.8061,"value":1964.27,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2200,"source":{"system":"sec-edgar","filing":"0001178913-22-000217","document":"zk2227103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891322000217/zk2227103.xml","form_type":"4"}},{"id":2427590,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2022-01-24T21:15:59.000Z","date":"2022-01-18","kind":"purchase","acquired":true,"shares":700,"price":2.8003,"value":1960.21,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2200,"source":{"system":"sec-edgar","filing":"0001178913-22-000217","document":"zk2227103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891322000217/zk2227103.xml","form_type":"4"}},{"id":2437545,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-11T21:10:55.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":107557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest ratably on a quarterly basis over a three-year period that commenced on January 1, 2022."}],"balance_after":107557,"derivative":{"exercise_price":2.815,"expiration_date":"2032-01-01","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":107557},"source":{"system":"sec-edgar","filing":"0001178913-22-000093","document":"zk2227046.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891322000093/zk2227046.xml","form_type":"4"}},{"id":2437544,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-11T21:10:55.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":35852,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2022."}],"balance_after":35852,"derivative":{"exercise_price":2.815,"expiration_date":"2032-01-01","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":35852},"source":{"system":"sec-edgar","filing":"0001178913-22-000093","document":"zk2227046.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234346/000117891322000093/zk2227046.xml","form_type":"4"}},{"id":2667205,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2021-06-16T12:19:04.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":14479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 14, 2021 and vest on June 14, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 14, 2021 and vest on June 14, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":14479,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14479},"source":{"system":"sec-edgar","filing":"0001209191-21-040810","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121040810/doc4.xml","form_type":"4"}},{"id":2674692,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2021-06-10T11:42:04.000Z","date":"2021-06-09","kind":"exercise","acquired":false,"shares":12668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 9, 2020 and vested on June 9, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 9, 2020 and vested on June 9, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12668},"source":{"system":"sec-edgar","filing":"0001209191-21-039371","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121039371/doc4.xml","form_type":"4"}},{"id":2674691,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-06-10T11:42:04.000Z","date":"2021-06-09","kind":"exercise","acquired":true,"shares":12668,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":54628,"source":{"system":"sec-edgar","filing":"0001209191-21-039371","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121039371/doc4.xml","form_type":"4"}},{"id":2678398,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2021-06-08T11:27:14.000Z","date":"2021-06-05","kind":"exercise","acquired":false,"shares":6041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 5, 2018 and vested on June 5, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 5, 2018 and vested on June 5, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6041},"source":{"system":"sec-edgar","filing":"0001209191-21-038815","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121038815/doc4.xml","form_type":"4"}},{"id":2678397,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-06-08T11:27:14.000Z","date":"2021-06-05","kind":"exercise","acquired":true,"shares":6041,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":41960,"source":{"system":"sec-edgar","filing":"0001209191-21-038815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121038815/doc4.xml","form_type":"4"}},{"id":3059346,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2020-08-13T20:12:07.000Z","date":"2020-08-11","kind":"exercise","acquired":false,"shares":7956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on August 11, 2017 and vested on August 11, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on August 11, 2017 and vested on August 11, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7956},"source":{"system":"sec-edgar","filing":"0001209191-20-046591","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120046591/doc4.xml","form_type":"4"}},{"id":3059345,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-08-13T20:12:07.000Z","date":"2020-08-11","kind":"exercise","acquired":true,"shares":7956,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":35919,"source":{"system":"sec-edgar","filing":"0001209191-20-046591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120046591/doc4.xml","form_type":"4"}},{"id":3111169,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2020-06-15T11:34:23.000Z","date":"2020-06-11","kind":"exercise","acquired":false,"shares":17621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 11, 2019 and vested on June 11, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 11, 2019 and vested on June 11, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17621},"source":{"system":"sec-edgar","filing":"0001209191-20-036498","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120036498/doc4.xml","form_type":"4"}},{"id":3111168,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-06-15T11:34:23.000Z","date":"2020-06-11","kind":"exercise","acquired":true,"shares":17621,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":27963,"source":{"system":"sec-edgar","filing":"0001209191-20-036498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120036498/doc4.xml","form_type":"4"}},{"id":3114018,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2020-06-11T11:13:08.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":12668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 9, 2020 and vest on June 9, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 9, 2020 and vest on June 9, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":12668,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12668},"source":{"system":"sec-edgar","filing":"0001209191-20-035784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120035784/doc4.xml","form_type":"4"}},{"id":3491985,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2019-06-13T10:11:51.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":17621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 11, 2019 and vest on June 11, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 11, 2019 and vest on June 11, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":17621,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17621},"source":{"system":"sec-edgar","filing":"0001209191-19-036585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119036585/doc4.xml","form_type":"4"}},{"id":3519504,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2019-05-20T11:13:00.000Z","date":"2019-05-16","kind":"exercise","acquired":false,"shares":2780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on May 16, 2016 and vested on May 16, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on May 16, 2016 and vested on May 16, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2780},"source":{"system":"sec-edgar","filing":"0001209191-19-031211","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119031211/doc4.xml","form_type":"4"}},{"id":3519503,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-20T11:13:00.000Z","date":"2019-05-16","kind":"exercise","acquired":true,"shares":2780,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":10342,"source":{"system":"sec-edgar","filing":"0001209191-19-031211","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119031211/doc4.xml","form_type":"4"}},{"id":3826339,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2018-09-05T20:09:31.000Z","date":"2018-09-03","kind":"exercise","acquired":false,"shares":2162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on October 7, 2015 and vested on September 3, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on October 7, 2015 and vested on September 3, 2018."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2162},"source":{"system":"sec-edgar","filing":"0001209191-18-049518","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118049518/doc4.xml","form_type":"4"}},{"id":3826338,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-09-05T20:09:31.000Z","date":"2018-09-03","kind":"exercise","acquired":true,"shares":2162,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":7562,"source":{"system":"sec-edgar","filing":"0001209191-18-049518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118049518/doc4.xml","form_type":"4"}},{"id":3902677,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2018-06-07T10:47:39.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":6041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 5, 2018 and vest on June 5, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 5, 2018 and vest on June 5, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":6041,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6041},"source":{"system":"sec-edgar","filing":"0001209191-18-036198","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118036198/doc4.xml","form_type":"4"}}]}